Related Experiment Video
Updated: Jun 27, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Priority order of neonatal colonization by a probiotic or pathogenic Escherichia coli strain dictates the host
Tomas Hudcovic1, Petra Petr Hermanova1, Hana Kozakova1
1Laboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Nový Hrádek, Czechia.
Insights
Early colonization with probiotic Escherichia coli Nissle 1917 protects against pathogenic E. coli O6:K13:H1-induced colitis. Sequential colonization, not single dose, establishes protective anti-inflammatory effects in the gut microbiome.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD) in children is linked to microbiome imbalances.
- Pathogenic Escherichia coli (E. coli) strains may worsen IBD.
- Identifying bacteria that drive inflammation is crucial.
Purpose of the Study:
- Compare immunomodulatory effects of probiotic E. coli Nissle 1917 and pathogenic E. coli O6:K13:H1.
- Investigate bacterial adherence and invasion of epithelial cells.
- Assess the impact of colonization sequence on immune response and colitis development.
Main Methods:
- In vitro studies using Caco-2 cells and mouse bone marrow-derived dendritic cells (BM-DCs).
- Gnotobiotic mouse models for in vivo colonization and experimental colitis induction (DSS).
- Comparison of early vs. single-dose administration of E. coli Nissle 1917.
Main Results:
- E. coli Nissle 1917 modulated Th1 immune response in vitro.
- Neonatal colonization with E. coli Nissle 1917 established high intestinal levels and protected against E. coli O6:K13:H1-induced colitis.
- Single-dose E. coli Nissle 1917 was ineffective in preventing colitis.
- Early colonization by E. coli Nissle 1917 showed beneficial competitive interaction with E. coli O6:K13:H1.
Conclusions:
- The sequence of bacterial colonization significantly influences gut immune response.
- Early colonization with probiotic E. coli Nissle 1917 confers protection against pathogenic E. coli-driven colitis.
- Beneficial competitive interactions between colonizing bacteria suggest anti-inflammatory potential.
Abstract:
The alarming prevalence of inflammatory bowel disease (IBD) in early childhood is associated with imbalances in the microbiome, the immune response, and environmental factors. Some pathogenic Escherichia coli (E. coli) strains have been found in IBD patients, where they may influence disease progression. Therefore, the discovery of new harmful bacterial strains that have the potential to drive the inflammatory response is of great importance. In this study, we compared the immunomodulatory properties of two E. coli strains of serotype O6: the probiotic E. coli Nissle 1917 and the uropathogenic E. coli O6:K13:H1. Using the epithelial Caco-2 cell line, we investigated the different abilities of the strains to adhere to and invade epithelial cells. We confirmed the potential of E. coli Nissle 1917 to modulate the Th1 immune response in a specific manner in an in vitro setting by stimulating mouse bone marrow-derived dendritic cells (BM-DCs). In gnotobiotic in vivo experiments, we demonstrated that neonatal colonization with E. coli Nissle 1917 achieves a stable high concentration in the intestine and protects mice from the progressive effect of E. coli O6:K13:H1 in developing ulcerative colitis in an experimental model. In contrast, a single-dose treatment with E. coli Nissle 1917 is ineffective in achieving such high concentrations and does not protect against DSS-induced ulcerative colitis in mice neonatally colonized with pathobiont E. coli O6:K13:H1. Despite the stable coexistence of both E. coli strains in the intestinal environment of the mice, we demonstrated a beneficial competitive interaction between the early colonizing E. coli Nissle 1917 and the late-arriving strain O6:K13:H1, suggesting its anti-inflammatory potential for the host. This study highlights the importance of the sequence of bacterial colonization, which influences the development of the immune response in the host gut and potentially impacts future quality of life.
Related Concept Videos
Introduction to the Human Microbiota
Development of Human Microbiota
Development of the Oral Microbiota
Microbiota of the Stomach and Small Intestine
Colonisation of Pathogens
Bacterial Gastroenteritis

